Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
Nestlé is acquiring dietary supplement manufacturer Atrium Innovations for $2.3 billion in cash. The deal, expected to close in the first quarter of 2018, will allow Nestlé to pursue growth opportunities in consumer healthcare to complement the company’s focus on its high-growth food and beverage categories.
December 6, 2017
Nestlé has agreed to acquire privately-held dietary supplement manufacturer Atrium Innovations for $2.3 billion in cash. The deal, expected to close in the first quarter of 2018, will allow Nestlé to pursue growth opportunities in consumer healthcare to complement the company’s focus on its high-growth food and beverage categories.
Atrium’s brands are a natural complement to the Nestlé consumer care portfolio, which offers nutritional solutions in the areas of healthy aging, healthy growing, gut health and obesity care.
“Atrium’s portfolio will extend our product range with value-added solutions such as probiotics, plant-based protein nutrition, meal replacements and an extensive multivitamin line, enabling consumers to address their health and wellness goals,” said Greg Behar, Nestlé health science CEO. “It also represents additional offerings in the segment for non-GMO, organic and natural supplements, a fast-growing consumer trend, as well as a new sales channel.”
Atrium’s 2017 sales are expected to reach almost $700 million. Upon closing, Atrium will become part of Nestlé Health Science. Its existing management team will continue to manage the business, led by Peter Luther, Atrium Innovations president and CEO.
Atrium’s largest brand, Garden of Life®, is a leading brand in the U.S. natural supplement and manufactures certified organic, non-GMO supplements. Pure Encapsulations® is a full line of hypoallergenic, research-based dietary supplements, and is a leading recommended brand in the U.S. practitioner market. Pure Encapsulations’ product line is free from food allergens, GMOs, fillers, binders and artificial colors. Other specialty brands in the Atrium portfolio include Wobenzym®, Douglas Laboratories®, Genestra Brands™, Orthica®, AOV®, Minami®, Klean Athlete®, Pharmax and Trophic™.
Content Director, Informa Markets Health & Nutrition
Judie Bizzozero oversees food and beverage content strategy and development for the Health & Nutrition group at Informa Markets (which acquired VIRGO in 2014), including the Food & Beverage Insider, Natural Products Insider and SupplySide/Food ingredients North America brands. She reports on market trends, science-based ingredients, and challenges and solutions in the development of healthy foods and beverages. Bizzozero graduated from the Walter Cronkite School of Journalism and Mass Communication at Arizona State University in 1987 with a bachelor’s degree in journalism.
You May Also Like
Dr. Mercola allegedly plans to introduce psychic advisor to followersMar 1, 2024
The Vitamin Shoppe general counsel criticizes NY age-restriction lawMar 1, 2024
Is kratom a safe life-giver or a dangerous life-taker?Mar 1, 2024
Patents can offer supplement brands competitive advantageMar 1, 2024